Vivus (VVUS) is raising the bar on erectile dysfunction drugs, potentially becoming the latest formidable competitor to Viagra and Cialis in the $3.8 billion market. Investors in the California-based

As expected, most industries have retrenched during this recession. Not so the pharmaceutical industry: It keeps spending, and spending, and spending -- on lobbying, to beat back health-care reform,

It’s a common problem. You’re sitting down with the kids to watch a wholesome episode of Desperate Housewives on Sunday, only to have a Viagra commercial suddenly pop up. The embarrassmen

Senator Barack Obama is a either a naïf or a ninny. Based on his tax proposals, the key to any economic program, the nincompoop out-points the naïf. Here’s why: Obama proposes to rais

Imagine you’re running a marathon. Against incredible odds, you’re in first place. The finish line is just yards away; as you cross it, triumphant, the feeling of ecstasy immediately vani

Volatile swings and crushing losses in the stock market are enough to drive you crazy. Literally. The phones of psychologists in New York have been ringing off the hook as Wall Street’s executi

While October may be the cruelest month, its final week was even crueler: It gave us false hope. The Dow was up 10%, the S&P was up 11% - their biggest one-week gains since 1974. Even staid blue-

BRIC Stocks Cheap, ScaryEven after a record 20% gain in emerging-market stocks last week, some of the world’s biggest money managers think tougher times lie ahead for the BRIC nations (Bra

The private sector is actively engaging the mortgage crisis with the first broad-based, systemic attempt to prevent foreclosure. Both Bank of America (BAC) and JPMorgan (JPM) are attempting to h

The mortgage bailout parade marches on. Just days after rival Bank of America (BAC) announced plans to modify hundreds of thousands of mortgages, JPMorgan (JPM) released details of a homeowner rescue